Colgate-Palmolive
CL Β· Household Products
$94.04
3.4%Reynolds Consumer Products
REYN Β· Household Products
$23.02
2.5%The short version
- Colgate-Palmolive is the larger business, with $20.4B of revenue in fiscal 2025 against $3.7B for Reynolds Consumer Products, about 5.5 times as much.
- Colgate-Palmolive grew revenue faster (1.4%, against 0.7%).
- Colgate-Palmolive turned more of its sales into free cash flow (17.8% FCF margin, against 8.5% FCF margin).
- Colgate-Palmolive earned a higher return on the capital invested in it (37.3%, against 9.9%).
- Investors pay more for each dollar of Colgate-Palmoliveβs earnings: a P/E of 37.2x against 14.7x for Reynolds Consumer Products.
| Latest fiscal year | CL Β· FY25 | REYN Β· FY25 |
|---|---|---|
| Size | ||
| Market cap | $75.4B | $4.9B |
| Revenue | $20.4B | $3.7B |
| Free cash flow | $3.6B | $316M |
| Net income | $2.1B | $301M |
| Growth | ||
| Revenue growth | 1.4% | 0.7% |
| 5-year growth | 4.4% | 2.7% |
| Share count change | β1.5% | 0.0% |
| Profitability | ||
| Gross margin | 60.1% | 24.6% |
| Operating margin | 16.2% | β |
| Net margin | 10.5% | 8.1% |
| FCF margin | 17.8% | 8.5% |
| Return on capital | 37.3% | 9.9% |
| Return on equity | β | 13.7% |
| Balance sheet | ||
| Net debt | $6.4B | $1.5B |
| Net debt / EBITDA | 1.6x | 2.4x |
| Dividends and buybacks | $3.0B | $192M |
| Valuation & quality | ||
| P/E | 37.2x | 14.7x |
| Piotroski F-score | 5 | 5 |
FY16
CL $15.2B
REYN β
FY17
CL $15.5B
REYN β
FY18
CL $15.5B
REYN $3.1B
FY19
CL $15.7B
REYN $3.0B
FY20
CL $16.5B
REYN $3.3B
FY21
CL $17.4B
REYN $3.6B
FY22
CL $18.0B
REYN $3.8B
FY23
CL $19.5B
REYN $3.8B
FY24
CL $20.1B
REYN $3.7B
FY25
CL $20.4B
REYN $3.7B
CL
REYN
FY16
CL 26.0%
REYN β
FY17
CL 24.0%
REYN β
FY18
CL 23.8%
REYN β
FY19
CL 22.7%
REYN β
FY20
CL 23.6%
REYN β
FY21
CL 19.1%
REYN β
FY22
CL 16.1%
REYN β
FY23
CL 20.5%
REYN β
FY24
CL 21.2%
REYN β
FY25
CL 16.2%
REYN β
CL
REYN
FY16
CL $2.5B
REYN β
FY17
CL $2.5B
REYN β
FY18
CL $2.6B
REYN $448M
FY19
CL $2.8B
REYN $294M
FY20
CL $3.3B
REYN $176M
FY21
CL $2.8B
REYN $169M
FY22
CL $1.9B
REYN $91.0M
FY23
CL $3.0B
REYN $540M
FY24
CL $3.5B
REYN $369M
FY25
CL $3.6B
REYN $316M
CL
REYN
FY16
CL 50.9%
REYN β
FY17
CL 44.0%
REYN β
FY18
CL 49.2%
REYN β
FY19
CL 41.6%
REYN β
FY20
CL 41.1%
REYN 17.8%
FY21
CL 33.9%
REYN 10.0%
FY22
CL 26.5%
REYN 8.3%
FY23
CL 34.3%
REYN 10.2%
FY24
CL 45.9%
REYN 11.6%
FY25
CL 37.3%
REYN 9.9%
CL
REYN
Add another company
Compare up to four at once.
Each company's latest fiscal year; fiscal years end in different months. The best value in each row is highlighted where higher (or lower) is clearly better. Not investment advice.